Spruce Biosciences kondigt prijsstelling aan van aandelenemissie en warrants

Spruce Biosciences has announced the pricing of a public offering of common stock and pre-funded warrants, according to a company statement. Such offerings are typically used by biotech firms to raise capital for operations or development programs. The move may affect the company's share structure and existing stockholders.